Forefront Wealth Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$1.06M Sell
10,072
-90
-0.9% -$8.45K 0.76% 36
2025
Q3
$853K Hold
10,162
0.63% 38
2025
Q2
$804K Hold
10,162
0.64% 36
2025
Q1
$912K Sell
10,162
-90
-0.9% -$8.4K 0.84% 32
2024
Q4
$1.02M Buy
+10,252
New +$1.06M 0.94% 29
2023
Q3
$1.06M Hold
10,262
1.48% 23
2023
Q2
$1.18M Hold
10,262
1.57% 24
2023
Q1
$1.09M Hold
10,262
1.43% 24
2022
Q4
$1.14M Hold
10,262
1.53% 22
2022
Q3
$884K Buy
10,262
+100
+1% +$8.93K 1.23% 26
2022
Q2
$931K Hold
10,162
1.25% 27
2022
Q1
$834K Sell
10,162
-590
-5% -$46.5K 0.83% 30
2021
Q4
$824K Buy
+10,752
New +$856K 0.79% 31

Other funds holding MRK

Forefront Wealth Management's MRK Position: Q4 2025 in Review

Forefront Wealth Management reduced its Merck (MRK) stake by 0.89% in Q4 2025, selling an estimated $8.45K and leaving 10,072 shares worth $1.06M. The position accounts for 0.76% of the portfolio, ranked #36.

Forefront Wealth Management first reported a position in MRK in Q4 2021 and has held it in 13 quarters since. The position peaked at $1.18M in Q2 2023. 3,651 funds tracked by Wall St. Rank hold MRK as of Q4 2025.

  • Forefront Wealth Management held 10,072 shares of Merck worth $1.06M as of Q4 2025.
  • Forefront Wealth Management sold 90 Merck shares in Q4 2025, an estimated $8.45K.
  • Merck made up 0.76% of Forefront Wealth Management's portfolio in Q4 2025, its #36 holding.
  • Forefront Wealth Management first reported a position in Merck in Q4 2021 and has held it in 13 quarters since.
  • Forefront Wealth Management's Merck position peaked at $1.18M in Q2 2023.
  • 3,651 funds tracked by Wall St. Rank held Merck as of Q4 2025.

Based on Forefront Wealth Management's 13F filing for Q4 2025, filed 23 Jan 2026.